Wang Jiewen, Peng Mingjing, Oyang Linda, Shen Mengzhou, Li Shizhen, Jiang Xianjie, Ren Zongyao, Peng Qiu, Xu Xuemeng, Tan Shiming, Xia Longzheng, Yang Wenjuan, Li Haofan, Wu Nayiyuan, Tang Yanyan, Lin Jinguan, Liao Qianjin, Han Yaqian, Zhou Yujuan
The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Hunan Key Laboratory of Cancer Metabolism, 283 Tongzipo Road, Changsha, 410013, Hunan, China.
Department of Oncology, Hunan Provincial People's Hospital (The First-Affiliated Hospital of Hunan Normal University), 61 Jiefang West Road, Changsha, 410005, Hunan, China.
Cell Biosci. 2025 Jun 4;15(1):76. doi: 10.1186/s13578-025-01415-9.
Lactate is a crucial product of cancer metabolism, creating an acidic environment that supports cancer growth and acts as a substrate for lactylation. Lactylation, a newly discovered epigenetic modification, plays a vital role in cancer cell signaling, metabolic reprogramming, immune response, and other functions. This review explores the regulation of lactylation, summarizes recent research on its role in cancers, and highlights its application in cancer drug resistance and immunotherapy. These insights aim to provide new avenues for targeting lactylation in cancer therapy.
乳酸是癌症代谢的关键产物,它营造了一个支持癌症生长的酸性环境,并作为乳酰化的底物。乳酰化是一种新发现的表观遗传修饰,在癌细胞信号传导、代谢重编程、免疫反应及其他功能中发挥着至关重要的作用。本综述探讨了乳酰化的调控机制,总结了其在癌症中作用的最新研究,并强调了其在癌症耐药性和免疫治疗中的应用。这些见解旨在为癌症治疗中靶向乳酰化提供新途径。